ResearcherJiaxing UniversityActive in the last 2 years

Siqi Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3678-7912; OpenAlex author ID A5101577365. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy. Co-author DOI 10.3389/fimmu.2025.1578870 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoguang Wang · 1 shared paper, 2025 · strength 0.26
- Paper Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunothera… DOI 10.3389/fimmu.2025.1578870 ↗
Zhengwei Song · 1 shared paper, 2025 · strength 0.26
- Paper Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunothera… DOI 10.3389/fimmu.2025.1578870 ↗
Lingyu Hu · 1 shared paper, 2025 · strength 0.26
- Paper Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunothera… DOI 10.3389/fimmu.2025.1578870 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.